-A +A

imprimer la page

Press release

Geneviève Almouzni becomes Director of the Institut Curie Research Centre

Geneviève Almouzni becomes Director of the Institut Curie Research Centre

03/09/2013

The specialist in epigenetics, a rapidly expanding field of research, is the first woman since Irène Joliot-Curie to direct the Institut Curie’s research activities

NEW ALLIANCE FOR EUROPEAN EXCELLENCE AND COMPETITIVENESS IN LIFE SCIENCES

NEW ALLIANCE FOR EUROPEAN EXCELLENCE AND COMPETITIVENESS IN LIFE SCIENCES

27/05/2013

European research centres in life sciences gather to foster excellence in research, share knowledge, and influence policy

Immunology: when epigenetics "stabilize" the specialization of T-lymphocytes

Immunology: when epigenetics "stabilize" the specialization of T-lymphocytes

05/07/2012

Researchers from Institut Curie have just published works in Nature that show for the first time that an epigenetic mechanism, based on the "architecture" of genetic material, contributes to the specialization of certain cells of the immune system, called helper T-lymphocytes

Circulating tumor DNA in the blood: a new biomarker for cancer

Circulating tumor DNA in the blood: a new biomarker for cancer

20/06/2012

A study co-headed by two physician-researchers, Marc-Henri Stern and Olivier Lantz has shown for the first time the possibility to detect circulating tumor DNA in the blood of patients with metastastic eye melanoma.

Dbait molecules discovered to boost radiotherapy in clinical trial at Institut Curie

Dbait molecules discovered to boost radiotherapy in clinical trial at Institut Curie

24/05/2012

Dbait molecules, produced in the framework of the research carried out by Marie Dutreix's team at Institut Curie, are currently the object of a phase 1 clinical trial in patients with skin melanoma

Child cancer :discovery of a new type of bone sarcoma

Child cancer :discovery of a new type of bone sarcoma

03/05/2012

A joint Institut Curie/Inserm team headed by Dr. Olivier Delattre has discovered the existence of a new form of bone sarcoma, affecting mainly adolescents and young adults

Adult stem cells, new hopes for cell therapy

Adult stem cells, new hopes for cell therapy

30/04/2012

In a Perspective” published in Science Translational Medicine, Prof.

Adult stem cells, new hopes for cell therapy

Adult stem cells, new hopes for cell therapy

30/04/2012

In a Perspective” published in Science Translational Medicine, Prof. Daniel LOUVARD, Director of Institut Curie's Research Center, and his colleagues comment the publication of the works of Hans Clevers (Netherlands) and Mamoru Watanabe (Japan) on intestinal tissue regeneration from adult stem cells

Developmental biology: Discovery of a new principle of chromosome organization

Developmental biology: Discovery of a new principle of chromosome organization

12/04/2012

Discovered in 1882 by Walther Flemming, chromosomes, the molecular basis of genetic heredity, are still enigmatic, 130 years later. Part of the enigma is starting to be solved, as the team of Edith Heard has just revealed a new layer of their complex organization

Child cancer : discovery of genetic susceptibility factors for Ewing's tumors

Child cancer : discovery of genetic susceptibility factors for Ewing's tumors

13/02/2012

Ewing's tumor is a rare form of bone cancer that affects children, with a higher occurrence frequency among populations of European origin

Ovarian cancer : Discovery of two predictive signatures for tumor aggressiveness and response to treatment

Ovarian cancer : Discovery of two predictive signatures for tumor aggressiveness and response to treatment

21/11/2011

Fatima Mechta-Grigoriou's laboratory has discovered a dual molecular signature providing a prognosis value for ovarian cancers

Breast cancer : discovery of a risk marker for pulmonary metastases

Breast cancer : discovery of a risk marker for pulmonary metastases

07/09/2011

The expression level of the Kindlin-1 gene determines the risk of pulmonary metastases in women with breast cancer

Cancer Plan : Institut Curie awarded the Integrated Cancer Research Site (SIRIC) label by INCa, the French National Cancer Institute

Cancer Plan : Institut Curie awarded the Integrated Cancer Research Site (SIRIC) label by INCa, the French National Cancer Institute

22/06/2011

Paris, June 22st 2011. INCa’s international committee of experts approved Institut Curie’s application, which it deemed “of excellent quality and sufficiently complete” for the SIRIC label to be awarded in 2011.

Epigenetics : Embryo development The tango of chromosomes

Epigenetics : Embryo development The tango of chromosomes

20/04/2011

The choreography and rhythm of silencing of the X chromosome differ in humans, mice and rabbits

α3β1 integrin, an essential protein for lactation

α3β1 integrin, an essential protein for lactation

14/04/2011

When the team of Marina Glukhova, “turned off” the a3b1 integrin in certain cells of the mammary gland, mutant mice could no longer suckle

Epigenetic factors predict tumor evolution in patients

Epigenetic factors predict tumor evolution in patients

28/02/2011

Predicting tumor evolution in each patient is a major challenge in oncology

New observations undermine existing dogma on chromosome fragile sites

New observations undermine existing dogma on chromosome fragile sites

27/01/2011

Prof Michelle Debatisse's team, at Institut Curie, has recently published works in Nature that explain why DNA breaks tend to occur preferentially in specific chromosomal regions, called common fragile sites

Opening of the Center for Developmental Biology and Cancer

Opening of the Center for Developmental Biology and Cancer

14/10/2010

Inaugurated on 13 October 2008 by Valérie Pécresse, the Minister of Higher Education and Research, the Center for Developmental Biology and Cancer marks a new stage in the ambitious scientific and medical policy of the Institut Curie.

Contesting the monopoly of Myriad Genetics on testing for predisposition to breast and ovarian cancer

Contesting the monopoly of Myriad Genetics on testing for predisposition to breast and ovarian cancer

14/10/2010

Following the appeals procedures of 12 to 19 November 2008, the European Patent Office (Munich) has partly gone back on its previous decision, by granting the University of Utah, now owner of the patents of Myriad Genetics, a patent for a certain type of mutation. The University of Utah now in theory “owns” more than half of the identified mutations in the BRCA1 gene.

Angiogenesis : the missing link between oxidative stress, insulin secretion and aging

Angiogenesis : the missing link between oxidative stress, insulin secretion and aging

13/10/2010

At the Institut Curie, the Inserm Avenir team “Stress and Cancer”, directed by Fatima Mechta-Grigoriou, has discovered a new mode of action of free radicals in aging